Further, K12 CAR-T cells had prominent anti-leukemic activity in an intravenously (i.v.)injected Jurkat leukemia mouse model, with no detectable disease in three out of five mice treated with K12 CAR-T. The gene discussed is SECTM1; the disease is leukemia.